These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 22871980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Strategic pain management: the identification and development of the IAHPC opioid essential prescription package.
    Vignaroli E, Bennett MI, Nekolaichuk C, De Lima L, Wenk R, Ripamonti CI, Bruera E.
    J Palliat Med; 2012 Feb; 15(2):186-91. PubMed ID: 22014206
    [Abstract] [Full Text] [Related]

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Feb; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.
    Ishihara M, Ikesue H, Matsunaga H, Suemaru K, Kitaichi K, Suetsugu K, Oishi R, Sendo T, Araki H, Itoh Y, Japanese Study Group for the Relief of Opioid-induced Gastrointestinal Dysfunction.
    Clin J Pain; 2012 Jun; 28(5):373-81. PubMed ID: 22156893
    [Abstract] [Full Text] [Related]

  • 8. Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients.
    Ishihara M, Iihara H, Okayasu S, Yasuda K, Matsuura K, Suzui M, Itoh Y.
    Support Care Cancer; 2010 Dec; 18(12):1531-8. PubMed ID: 19921282
    [Abstract] [Full Text] [Related]

  • 9. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI, Walsh D, Brito-Dellan N.
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [Abstract] [Full Text] [Related]

  • 10. Multivariate analysis of countries' government and health-care system influences on opioid availability for cancer pain relief and palliative care: more than a function of human development.
    Gilson AM, Maurer MA, Lebaron VT, Ryan KM, Cleary JF.
    Palliat Med; 2013 Feb; 27(2):105-14. PubMed ID: 23104512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Management of opioid-induced bowel dysfunction.
    Levy MH.
    J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-22-6. PubMed ID: 23570134
    [Abstract] [Full Text] [Related]

  • 15. [Direct low-dose fentanyl patch (2.1mg) introduction for opioid naïve outpatients with cancer pain].
    Hata A, Katakami N, Masuda Y, Nanjo S, Otsuka K, Kaji R, Fujita S, Iwamori S, Mifune Y, Orita H, Fukae M, Yamatani T.
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):415-8. PubMed ID: 21403444
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Economic and clinical burden of opioid-induced nausea and vomiting.
    Nicholson BD.
    Postgrad Med; 2017 Jan; 129(1):111-117. PubMed ID: 27690715
    [Abstract] [Full Text] [Related]

  • 18. Nausea and vomiting side effects with opioid analgesics during treatment of chronic pain: mechanisms, implications, and management options.
    Porreca F, Ossipov MH.
    Pain Med; 2009 Jan; 10(4):654-62. PubMed ID: 19302436
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA, Gitlin MC.
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.